AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018
Aug 1, 2018
30339_dirs_2018-08-01_f32e8ec1-219d-418f-b1cd-4a25353b6bed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-08-01
Reporting Person: Lai Quintin J (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 659.8424 | Direct |
| Common Stock | 2913.70 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $55.20 | 2026-01-11 | Common Stock (5912.00) | Direct | |
| Stock Option (Right to Buy) | $59.64 | 2026-02-23 | Common Stock (8672.00) | Direct | |
| Stock Option (Right to Buy) | $72.97 | 2026-10-18 | Common Stock (1000.00) | Direct | |
| Stock Option (Right to Buy) | $83.47 | 2027-02-21 | Common Stock (5576.00) | Direct | |
| Stock Option (Right to Buy) | $94.27 | 2027-05-02 | Common Stock (2440.00) | Direct | |
| Stock Option (Right to Buy) | $89.64 | 2028-02-20 | Common Stock (8772.00) | Direct |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12